
Meinian Onehealth runs a multi-brand chain of preventive health-examination centres for employers and individual customers in China.
health-100.hkCrawled Nov 4, 2026
Endometrial cancer accounts for 20–30% of gynecological malignancies and poses a growing risk, with rising incidence and younger affected ages.
Meirun offers verified health knowledge on various topics, including health tips and wellness, reviewed by its professional medical team.
美年 provides verified health information, including tips and wellness news, reviewed by its professional medical team.
Founded in 2004, 美年健康 is a leading health checkup and medical group in China, headquartered in Shanghai. It operates four brands—美年大健康, 慈銘, 慈銘奧亞, and 美兆—and has over 600 centers across nearly 300 cities. With 65,000 employees, including 35,000 medical professionals, it serves around 30 million annual clients and has provided checks for 200 million people since its 2015 IPO.
美年大健康 offers targeted health check packages for men, women, seniors, and pregnant individuals, including full-body exams in Hong Kong.
Meinian Onehealth Healthcare Holdings Co., Ltd. reports **CNY 6.58 billion in sales** for the nine months ended September 30, 2026, a decline from **CNY 6.93 billion** in the same period last year. The company’s **net income rises to CNY 96.41 million**, up from **CNY 51.86 million** year-over-year. The earnings reflect a shift in revenue performance amid improved profitability.
Oct 2026MarketScreenerNews article
The Shenzhen Stock Exchange suspends Meinan Onehealth’s review of its multi-asset acquisition via share issuance due to expired financial data. The company’s application relied on outdated figures from September 30, 2025, which no longer meet regulatory requirements. The suspension halts progress on the proposed deal until updated financials are submitted.
Jun 2026FilingReaderNews article
Meinian Onehealth Healthcare Holdings experienced a **20% stock price surge** over three trading sessions (January 8, 9, and 12, 2026) ahead of its annual results. The company’s board and controller investigated the fluctuations and confirmed no undisclosed material matters or ongoing negotiations influenced the share price. Regulators are now reviewing the abnormal trading activity.
Jan 2026FilingReaderNews article
Alibaba’s affiliates acquire stakes in Meinian Onehealth Healthcare, a Shanghai-based health conglomerate specializing in physical examinations. The investment totals **USD 1 billion**, as disclosed in Meinian’s filing with the Shenzhen Stock Exchange. The move strengthens Alibaba’s presence in China’s healthcare sector through strategic partnerships.
Oct 2019KrASIANews article